47 results on '"Rosati, Emanuela"'
Search Results
2. Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia
3. A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect
4. Therapeutic targeting of chronic lymphocytic leukemia by silver nanoparticles
5. Figure S10 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
6. Figure S4 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
7. Figure S5 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
8. Figure S2 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
9. Figure S5 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
10. Figure S1 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
11. Figure S3 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
12. Figure S6 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
13. Figure S8 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
14. Figure S9 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
15. Figure S7 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
16. Immune correlates of protection by vaccine against SARS‐CoV ‐2 in patients with chronic lymphocytic leukaemia
17. GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL
18. NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications
19. NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status
20. NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models
21. Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
22. IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation
23. NOTCH and Graft-Versus-Host Disease
24. NOTCH1 Aberrations in Chronic Lymphocytic Leukemia
25. NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells
26. Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia
27. Subclones in B-lymphoma cell lines: isogenic models for the study of gene regulation
28. Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL
29. Macrophage induced gelsolin in response to Group BStreptococcus(GBS) infection
30. Impairment of brain mitochondrial functions by β-hemolytic Group B Streptococcus. Effect of cardiolipin and phosphatidylcholine
31. NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion
32. A novelNOTCH1PEST domain mutation in a case of chronic lymphocytic leukemia
33. Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction
34. γ‐Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down‐regulation
35. Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation
36. Group B Streptococcus (GBS) disrupts by calpain activation the actin and microtubule cytoskeleton of macrophages
37. Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL
38. NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL
39. A new genetic lesion in B‐CLL: a NOTCH1 PEST domain mutation
40. Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells
41. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo
42. B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor α
43. Graft engineering for allogeneic haploidentical stem cell transplantation
44. Apoptosis of human primary B lymphocytes is inhibited by N-acetyl-L-cysteine
45. Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells
46. Group BStreptococcusInduces Apoptosis in Macrophages
47. Antibody-independent protection in mice against type Ia group B streptococcus lethal infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.